Sun Pharma
Signals mentioning Sun Pharma
- NPPA caps retail prices for 23 new drug formulations in India
- Sun Pharma recalls 10 eye-drop brands over possible contamination
- Sun Pharma recalls 10 eye-drop brands over contamination concerns
- Sun Pharma recalls select eye drops in India after contamination concern
- Sun Pharma halts distribution and recalls multiple eye-drop products as a precaution
- Sun Pharma Q1FY27 profit rises 27% as India formulations grow 16%
- HDFC Securities sees FY27 consumer recovery, but input volatility clouds margins
- India pharma market grows 16% as drugmakers enter US tariff-free transition
- GTRI flags proposed US generic-drug tariffs as major risk for Indian pharma exporters
- Indian generic drugmakers face potential US tariff shock from 2028
- Titan Sets Aug 7 Board Meet for Q1 FY27 Results Amid Gold Demand Surge
- Analysts Flag Buy On Swiggy, Hold On Varun Beverages In Latest Retail Consumer Calls
- Clinikally goes omnichannel with first Gurugram experience centre, eyes 12-15 stores by mid-2027
- Semaglutide channel chokes on Rs 100cr excess stock as April generic rush fades
- India M&A and PE deal value halves to $10.2B in May after April's $21.8B spike
- Patni family launches Raay Neo Pharma, targeting Tier 2/3 cities with 15-20% cheaper generics
- Pine Labs, Hyundai land on brokerage radar as analysts flag fresh stock picks
- Pregabalin moved to Schedule H1; ₹1,800 cr segment faces tighter chemist compliance
- 190+ companies report Q4FY26 today; Colgate, Eicher Motors headline consumer-facing prints
- Q4 earnings: ITC profit +5% to ₹5,113 cr; Nykaa nearly 4x; Honasa +176%